Senolytics a double edged sword?

Good science relies on being open to new findings and changing ones approach based on new information. The subject of Senolytics is another such example where it has the potential to be beneficial but could also prove to be detrimental too. This is one of the reasons why the MMTP is testing Senolytics in robust lifespan testing to explore the possibilities of this new medical approach and to see if it has positive or negative effects or perhaps both.

World Cancer Day

World Cancer Day

by Elena Milova


Some potential interventions to ameliorate degenerative aging

The progress science is making to understand the biological processes involved in aging is rapidly advancing as is the potential for therapies and technology to intervene against these processes in order to promote healthy and longer lives.